Topical fluconazole for experimental candida keratitis in rabbits.
Using a reproducible model of Candida albicans keratitis in rabbits we studied the effect of topical fluconazole, a new triazole. Candida albicans DSM 70010 (2.5 X 10(5) cells) was injected into the corneal stroma of both eyes of 21 rabbits. All eyes developed a corneal ulcer. Forty-eight hours after inoculation the animals were divided into three groups: (1) 14 eyes, received fluconazole (2 mg/ml) and the epithelium subsequently removed; (2) 14 eyes, received only fluconazole drops; (3) 14 eyes, received 0.9% NaCl: half of this group was also debrided. We applied one drop of either substance 10 times a day for 24 days. A further six rabbits were used to judge if the drug penetrated into the cornea and aqueous humour. There was a highly significant difference between the fluconazole groups (1,2) and the control group (3) as to hypopyon and complications (descemetocele, corneal perforation) as well as recultivation of C. albicans from corneal tissue. The difference between the fluconazole groups with and without debridement was not significant. The drug penetrated into the cornea and aqueous humour of both uninflamed and inflamed eyes.
Behrens-Baumann
W
W
Department of Ophthalmology, University of Göttingen, FRG.
Klinge
B
B
Rüchel
R
R
D000287:Administration, Topical; D000818:Animals; D001082:Aqueous Humor / Q000378:metabolism; D001682:Biological Availability; D002177:Candidiasis / Q000188:drug therapy*; D003315:Cornea / Q000378:metabolism; D015725:Fluconazole / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007634:Keratitis / Q000188:drug therapy* / Q000209:etiology; D009883:Ophthalmic Solutions; D011817:Rabbits
D009883:Ophthalmic Solutions; D015725:Fluconazole